Inhibikase Therapeutics Inc (IKT)

[jedijazz]

Recent PRESS RELEASES

MAY 25, 2021 8:00AM EDT
Inhibikase Therapeutics to Present at Upcoming Jefferies Virtual Healthcare Conference & Others
MAY 17, 2021 4:05PM EDT
Inhibikase Therapeutics Reports First Quarter 2021 Financial Results and Highlights Recent Period Activity
APR 21, 2021 8:00AM EDT
Inhibikase Therapeutics to Present at Sachs 4th Annual Neuroscience Innovation Forum
APR 01, 2021 8:00AM EDT
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
MAR 02, 2021 8:05AM EST
Inhibikase Therapeutics to Present at H.C. Wainwright & Co. Global Life Sciences Virtual Conference
FEB 22, 2021 8:05AM EST
Inhibikase Therapeutics to Present at the American Society of Experimental Neurotherapeutics (ASENT) Conference
FEB 17, 2021 8:05AM EST
Inhibikase Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial of IkT-148009 to Treat Parkinson’s Disease and Related Disorders
JAN 04, 2021 8:01AM EST
Inhibikase Therapeutics Announces Partnership with Clintrex Research Corporation; C. Warren Olanow, MD, to Serve as Interim Chief Medical Officer
DEC 28, 2020 10:33AM EST
Inhibikase Therapeutics Announces Closing of Initial Public Offering